INNDYDOZZER – Trademark Portfolio
Entity Type: 03
INNDYDOZZER holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include QDNA and QUANTUM DNA ACCELERATION. The owner is based in MALIBU, CA.
MALIBU, CA 90265
Showing of trademarks Trademarks
Trademark Classifications
INNDYDOZZER's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does INNDYDOZZER have?
INNDYDOZZER has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does INNDYDOZZER file in?
INNDYDOZZER files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are INNDYDOZZER's most well-known trademarks?
INNDYDOZZER's registered trademark portfolio includes well-known marks such as QDNA and QUANTUM DNA ACCELERATION. These are among 2 currently registered trademarks in the portfolio.
What is INNDYDOZZER's trademark registration success rate?
INNDYDOZZER has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.